Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FIT Biotech

Latest From FIT Biotech

Ebola – The industry's response in vaccines

The latest Ebola epidemic, which the WHO says has now claimed more than 9,600 lives, has focused attention on the long-term need for a prophylactic vaccine to prevent future outbreaks of this size.

Gastrointestinal Gynecology & Urology

Deals Shaping the Medical Industry (06/2009)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions Database, providing comprehensive transaction coverage from 1991 to the present.
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Finnish Immunotechnology Oy
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Finland
  • Parent & Subsidiaries
  • FIT Biotech
  • Senior Management
  • Erkki Pekkarinen, CEO
    Liisa Laitinen, VP, Fin. & Admin.
  • Contact Info
  • FIT Biotech
    Phone: (358) 3 3138 7000
    Biokatu 8
    Tampere, 33520